Physician profile
Keith Mootoo
NPI 1609904150
$2,163.83
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $364.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $363.99 | 2019-2020 | |
| Amgen INC. | $269.97 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $144.89 | 2019-2020 | |
| Pfizer INC. | $144.41 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $139.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $133.51 | 2019-2020 | |
| Amicus Therapeutics, INC. | $113.25 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $102.97 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $101.08 | 2019 | |
| Sanofi-Aventis U.S. LLC | $98.47 | 2019 | |
| Fresenius USA Marketing, INC. | $89.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.49 | 2019 | |
| Lilly USA, LLC | $70.46 | 2019 | |
| Novo Nordisk INC | $54.79 | 2019 | |
| Vifor Pharma, INC. | $42.32 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $36.86 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $29.00 | 2020 | |
| Genzyme Corporation | $22.91 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.46 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $18.27 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.22 | 2019 | |
| Horizon Therapeutics Plc | $16.41 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.02 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Mootoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.